Pancreatic cancer patient survival doubled with high dose of common vitamin, study finds
Fox News
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in pancreatic cancer patients. Study author Dr. Cullen and oncologists discuss.
The researchers found that administering 75 grams of vitamin C three times a week doubled overall survival rates of patients with late-stage metastatic pancreatic cancer from eight months to 16 months. "Vitamin C, which is inexpensive and well-tolerated, may improve the efficacy of chemotherapy with a good quality of life." Angelica Stabile is a lifestyle reporter for Fox News Digital.
The study, published in the journal Redox Biology, also found that progression-free survival was extended from four to six months.
More Related News